Related Experiment Video

Updated: Aug 19, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
07:38

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Published on: May 6, 2018

Olanzapine-induced acute rhabdomyolysis-a case report

U Baumgart, R Schmid, H Spiessl

    Pharmacopsychiatry
    |February 12, 2005
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
    10:44

    Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

    Published on: May 15, 2019

    Related Experiment Videos

    Last Updated: Aug 19, 2026

    Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
    07:38

    Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

    Published on: May 6, 2018

    Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
    10:44

    Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

    Published on: May 15, 2019

    Related Concept Videos

    Acute Kidney Injury I: Introduction01:22

    Acute Kidney Injury I: Introduction

    Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
    Acute Kidney Injury III: Clinical Manifestations01:29

    Acute Kidney Injury III: Clinical Manifestations

    Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...

    Articles linked to this work by shared authors, journal, and citation graph.

    [Implementation of the recommendations for psychotherapy after psychiatric inpatient treatment : Results of the PAKT study Part II].

    Der Nervenarzt·2016

    [Recommendations for psychotherapy in psychiatric inpatient treatment : Results of the PAKT Study Part I].

    Der Nervenarzt·2016

    Needs-oriented discharge planning for high utilisers of psychiatric services: multicentre randomised controlled trial.

    Epidemiology and psychiatric sciences·2011

    [Documentation in psychiatry and psychotherapy: prerequisites and clinical practice].

    Der Nervenarzt·2008

    [The situation of caregivers of inpatients with bipolar affective disorders].

    Fortschritte der Neurologie-Psychiatrie·2007

    [The psychiatrist and the psychiatric hospital--an analysis of referral and aftercare].

    Fortschritte der Neurologie-Psychiatrie·2007

    Mood destabilizers?: A review of mood stabilizer-associated mania.

    Pharmacopsychiatry·2026

    Effects of Etifoxine and Alprazolam on Pregnenolone, Cortisol, and 18-kDa Translocator Protein in Healthy Men: A Placebo-Controlled Study.

    Pharmacopsychiatry·2026

    Pipamperone metabolism by various recombinant cytochrome preparations.

    Pharmacopsychiatry·2026

    Lithium Prescription in Unipolar Depression: Findings from a Nationwide Greek Cohort Study.

    Pharmacopsychiatry·2026

    Guideline adherence in patients with long-term schizophrenia in Germany: Focus on clozapine and electroconvulsive therapy.

    Pharmacopsychiatry·2026

    Efficacy and tolerability of nutraceuticals and phytotherapics for antipsychotic-induced weight gain in schizophrenia spectrum disorders: Systematic review and meta-analysis.

    Pharmacopsychiatry·2026

    Aryl hydrocarbon receptor as a molecular mediator in the induction of human aldehyde oxidase gene expression.

    The Journal of pharmacology and experimental therapeutics·2026

    Colorimetric detection of H2O2 based on the synergistic catalytic enhancement effect of Fe3O4@NH2-MIL-88B.

    Analytical methods : advancing methods and applications·2026

    Circularly polarized electroluminescence from topologically chiral [2]catenane-based neutral radicals with tunable deep-red emission.

    Nature communications·2026

    Synthesis of Chiral-at-Sulfur(VI) Sulfonimidamide Brønsted Acids.

    Chemistry (Weinheim an der Bergstrasse, Germany)·2026

    Deaminative C(sp3)-C(sp2) and C(sp3)-S coupling of alkylamines.

    Chemical communications (Cambridge, England)·2026

    TiO2‑Mediated Enamine Radical Cation Cycloadditions: Divergent [4 + 2] and [2 + 2] Reactivity.

    Precision chemistry·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us